Octant Bio

Series-B+
octant.bio Biotech & Healthcare
Total Funding $35M
Latest Round Undisclosed Series-B+
Last Announced Oct 23, 2025
Investors Undisclosed
Decision Makers 6 Verified

About Octant Bio

Next-generation small molecule therapeutics. Drugging the cellular mechanisms that cause disease

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website octant.bio
Domain Registered Date Jun 5, 2017

Social & Network Presence

X / Twitter Profile @OctantBio (4.0K followers) Created on Jun 2017
LinkedIn Corporate Not linked

Company Milestones & Timeline

5 Events
  1. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  2. Capital Raise

    Raised $30,000,000 · Series-A

    startupintros.com

  3. Capital Raise

    Raised $5,000,000 · Seed

    startupintros.com

  4. Milestone

    X account created (@OctantBio)

    4.0K followers

  5. Milestone

    Website domain registered

    octant.bio

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Octant Bio.

Funding History

3 Rounds
Series-B+ · Oct 23, 2025
Series-A · May 1, 2020
Seed · Oct 1, 2017

Founders & Leadership

2

Ramsey Homsany

Cofounder & President

Work email & phone locked Unlock →

Sri Kosuri

Cofounder & CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts